Inventor · disambiguated record
Andreas Marzinzik
Also filed as: MARZINZIK ANDREAS
9 granted patents·10 pending applications·38 citations·filing 2006–2025
84Inventor score
Top patents by PatentIndex Score
19 records- 0186US8829195B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1DODD STEPHANIE KAY·Filed 2013·Granted Sep 9, 2014·16 cites·16 claims
- 0285US9340537B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted May 17, 2016·4 cites·3 claims
- 0385US9278981B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Mar 8, 2016·6 cites·18 claims
- 0478US8163773B2Organic compoundsBREITENSTEIN WERNER·Filed 2006·Granted Apr 24, 2012·6 cites·15 claims
- 0575US8309596B2Kallikrein 7 modulatorsFLOHR STEFANIE·Filed 2008·Granted Nov 13, 2012·6 cites·6 claims
- 0658US2018134695A1Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1FURET PASCAL·Filed 2018·Application pending·0 cites
- 0757US9896444B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Feb 20, 2018·0 cites·5 claims
- 0854US2025090699A1Fap targeting cyclic peptides and conjugates thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0952US12209144B2Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2019·Granted Jan 28, 2025·0 cites·1 claims
- 1051US9458112B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Oct 4, 2016·0 cites·8 claims
- 1150US9315489B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Apr 19, 2016·0 cites·20 claims
- 1248US2014343086A1Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1DODD STEPHANIE KAY·Filed 2014·Application pending·0 cites
- 1348US2012094958A1Quinolines as inhibitors of farnesyl pyrophosphate synthaseAMSTUTZ RENE·Filed 2009·Application pending·0 cites
- 1446US2025332300A1Her2 targeting cyclic peptides and conjugates thereofNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1545US2013028843A1Kallikrein 7 modulatorsNOVARTIS AG·Filed 2012·Application pending·0 cites
- 1644US2011288057A1Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitorsCOTESTA SIMONA·Filed 2009·Application pending·0 cites
- 1742US2008242698A1Organic CompoundsFLOR PETER JOSEF·Filed 2006·Application pending·0 cites
- 1834US2013085161A1Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivativesBERST FREDERIC·Filed 2011·Application pending·0 cites
- 1933US2013090342A1Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivativesBERST FREDERIC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Marzinzik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →